Compound Evidence File
#EC-2026-0982
DSIP
Filed under Peptides. The bureau holds 177 laboratory returns for this compound from 70 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
70 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 5 | 10.0 | 10.0 | 10.0 | 5 Jan 2026 | 10 Jul 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 4 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 10.0 | 9.9 | 10.0 | 6 Mar 2026 | 4 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Jan 2026 | 14 Mar 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 2 | 10.0 | 10.0 | 10.0 | 2 Jun 2026 | 4 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Mar 2026 | 7 Jun 2026 |
| Pura PeptidesCASE #VI-2026-0307 | X | 1 | 10.0 | 10.0 | 10.0 | 25 Apr 2025 | 25 Apr 2025 |
| QYAOBIOCASE #VI-2026-0861 | A | 4 | 9.9 | 9.9 | 10.0 | 17 Nov 2025 | 6 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 20 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 9.9 | 24 Jan 2026 | 28 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Feb 2026 | 15 Jul 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 10 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 1 Jun 2026 | 2 Aug 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 11 May 2026 | 18 Aug 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 9.9 | 9.9 | 10.0 | 28 May 2026 | 4 Aug 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 9.9 | 14 May 2026 | 7 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Mar 2026 | 4 Jun 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 16 Feb 2026 | 28 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 2 | 9.9 | 9.9 | 10.0 | 28 Dec 2025 | 28 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Mar 2026 | 16 Aug 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 2 | 9.9 | 9.9 | 10.0 | 28 Mar 2026 | 13 Apr 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Apr 2026 | 13 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 16 May 2026 | 16 Aug 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 9.2 | 8.4 | 10.0 | 25 May 2026 | 25 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 6 | 9.0 | 8.4 | 10.0 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 8.9 | 8.5 | 9.3 | 24 May 2026 | 24 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | C | 2 | 8.9 | 8.5 | 9.4 | 7 May 2025 | 17 May 2026 |
| Laicuinuo LCNCASE #VI-2026-0223 | X | 1 | 8.9 | 8.9 | 8.9 | 27 Feb 2025 | 27 Feb 2025 |
| Trusted PeptideCASE #VI-2026-0499 | X | 1 | 8.9 | 8.9 | 8.9 | 11 Jun 2025 | 11 Jun 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.8 | 8.3 | 9.2 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.6 | 7.8 | 9.5 | 23 May 2026 | 23 May 2026 |
| LipeptidesCASE #VI-2026-0863 | X | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 | 17 Dec 2024 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 8.6 | 8.6 | 8.6 | 17 Dec 2024 | 17 Dec 2024 |
| Peptide HavenCASE #VI-2026-0898 | X | 1 | 8.6 | 8.6 | 8.6 | 20 Jun 2025 | 20 Jun 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 8.4 | 8.4 | 8.4 | 11 Jun 2025 | 11 Jun 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 8.4 | 8.4 | 8.4 | 27 Feb 2025 | 27 Feb 2025 |
| UtherCASE #VI-2026-0902 | X | 3 | 8.3 | 6.9 | 9.9 | 6 May 2025 | 23 May 2026 |
| Bulk Peptide SupplyCASE #VI-2026-0446 | X | 2 | 8.2 | 7.3 | 9.1 | 17 Dec 2024 | 24 May 2026 |
| Mai PeptideCASE #VI-2026-0769 | X | 2 | 8.1 | 7.2 | 8.9 | 2 Apr 2025 | 20 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 2 | 8.1 | 6.5 | 9.7 | 3 Jun 2025 | 21 May 2026 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 8.1 | 8.1 | 8.1 | 2 Jul 2025 | 2 Jul 2025 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 7.9 | 7.9 | 7.9 | 25 Apr 2025 | 25 Apr 2025 |
| Lisa BiopeptideCASE #VI-2026-0131 | X | 1 | 7.9 | 7.9 | 7.9 | 24 Apr 2025 | 24 Apr 2025 |
| NexaphCASE #VI-2026-0944 | X | 5 | 7.2 | 6.0 | 8.3 | 16 Mar 2025 | 24 May 2026 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 7.0 | 7.0 | 7.0 | 8 Jul 2025 | 8 Jul 2025 |
| YimeiCASE #VI-2026-0081 | X | 4 | 6.9 | 5.6 | 9.1 | 21 May 2025 | 19 Jan 2026 |
| Bio PepzCASE #VI-2026-0436 | X | 1 | 6.9 | 6.9 | 6.9 | 14 Jan 2025 | 14 Jan 2025 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 4 | 6.8 | 3.1 | 9.6 | 11 Jun 2025 | 19 Jan 2026 |
| Shanxi Qianyecao Biotech QYCCASE #VI-2026-0189 | X | 6 | 6.5 | 3.2 | 8.4 | 11 Jun 2025 | 17 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 2 | 6.5 | 6.0 | 7.0 | 2 Apr 2025 | 25 May 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 6.2 | 6.2 | 6.2 | 13 Jun 2025 | 13 Jun 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 6.1 | 6.1 | 6.1 | 2 Jul 2025 | 2 Jul 2025 |
| ZLZ PeptideCASE #VI-2026-0524 | X | 11 | 6.0 | 4.6 | 7.7 | 11 Jun 2025 | 25 May 2026 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 3 | 5.9 | 4.7 | 7.0 | 9 Jun 2025 | 19 Jan 2026 |
| Huayi BiotechnologyCASE #VI-2026-0243 | X | 1 | 5.9 | 5.9 | 5.9 | 3 Jul 2025 | 3 Jul 2025 |
| Loti LabsCASE #VI-2026-0171 | X | 3 | 5.7 | 4.3 | 6.8 | 17 Dec 2024 | 17 May 2026 |
| BeiBangAnCASE #VI-2026-0899 | X | 2 | 5.7 | 5.5 | 5.9 | 27 Feb 2025 | 21 May 2026 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 5.2 | 5.2 | 5.2 | 2 Apr 2025 | 2 Apr 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 5.2 | 5.2 | 5.2 | 21 May 2025 | 21 May 2025 |
| TydesCASE #VI-2026-0493 | X | 3 | 4.7 | 3.3 | 6.7 | 28 Mar 2025 | 23 May 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 1 | 4.6 | 4.6 | 4.6 | 8 Jul 2025 | 8 Jul 2025 |
| PurePEPSCASE #VI-2026-0552 | X | 1 | 4.3 | 4.3 | 4.3 | 13 Jun 2025 | 13 Jun 2025 |
| Coastal PeptidesCASE #VI-2026-0958 | X | 2 | 3.9 | 3.4 | 4.4 | 13 Jun 2025 | 24 May 2026 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 3.7 | 3.7 | 3.7 | 27 Feb 2025 | 27 Feb 2025 |
| Peptide GurusCASE #VI-2026-0854 | X | 3 | 3.5 | 2.1 | 5.0 | 28 Mar 2025 | 20 May 2026 |
| HK Fat CatCASE #VI-2026-0376 | X | 1 | 0.3 | 0.3 | 0.3 | 24 Apr 2025 | 24 Apr 2025 |
| Guangzhou Yuao TradingCASE #VI-2026-0787 | X | 1 | 0.0 | 0.0 | 0.0 | 25 Apr 2025 | 25 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 11 Jun 2025 | 11 Jun 2025 |
Open any subject to view the batch-level evidence for DSIP alone.